Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review

Progress in Neuro-Psychopharmacology and Biological Psychiatry — | January 24, 2018

Reiche S, et al. – Researchers investigated serotonergic hallucinogens for the treatment of anxiety associated with life-threatening diseases. Because of their anxiolytic and antidepressant properties, serotonergic hallucinogens proved beneficial in patients with life threatening diseases associated with symptoms of depression and anxiety. In a clinical setting, substances exhibited a reasonable safety profile

Article on Progress in Neuro-Psychopharmacology and Biological Psychiatry